Role of Family History and Tumor Location on Prognosis of Patients with Colorectal Cancer and Synchronous Metastases
Overview
General Surgery
Authors
Affiliations
Background/aims: Family history of colorectal cancer and tumor location along colon-rectum have been reported as prognostic factors. The aim of the current study is to analyze the role of both on overall survival in a series of patients with metastatic colorectal cancer with synchronous metastases.
Methods: A retrospective mono-institutional analysis has been performed on patients, who received chemotherapy from 2004 to 2008. A Cox proportional-hazards regression was used to calculate hazard ratio (HR) for death, after adjustment for other variables (tumor metastasectomy, number of organs involved with metastases, number of anti-neoplastic drugs, age, sex, tumor grade, baseline CEA).
Results: Two hundred and seven patients were included in the study. Only tumor metastasectomy was related with a better overall survival (HR 4.995; P < 0.001), whereas a positive family history was associated with a poor prognosis (HR 0.386; P = 0.021). After exclusion of rectal tumors, the negative prognostic effect of a positive family history appeared limited to patients with a left-sided colon cancer (HR 0.183; P = 0.036).
Conclusion: Family history for colorectal cancer in a first-degree relative, and not tumor location, has a significant relationship with the prognosis of patients with a colorectal cancer and synchronous metastases.
Ma Z, Li Z, Wang H, Wang R, Han X Se Pu. 2022; 40(6):541-546.
PMID: 35616199 PMC: 9404029. DOI: 10.3724/SP.J.1123.2022.01001.
Therapeutic Effect and Prognosis of Biliary Tract Tumor Transformation.
Shang P, Yu Y, Yan P, Xu H Comput Math Methods Med. 2022; 2022:9489003.
PMID: 35547567 PMC: 9085330. DOI: 10.1155/2022/9489003.
27-hydroxycholesterol decreases cell proliferation in colon cancer cell lines.
Warns J, Marwarha G, Freking N, Ghribi O Biochimie. 2018; 153:171-180.
PMID: 30009860 PMC: 6390838. DOI: 10.1016/j.biochi.2018.07.006.